All Stories

  1. Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease
  2. Genetic Susceptibility to Chronic Kidney Disease – Some More Pieces for the Heritability Puzzle
  3. Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection
  4. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
  5. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis
  6. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population
  7. Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes
  8. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease
  9. Long-Term Outcomes of Renal Transplant in Recipients With Lower Urinary Tract Dysfunction
  10. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
  11. Risk prediction for acute kidney injury in acute medical admissions in the UK
  12. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England
  13. Cardiovascular risk in renal transplant recipients
  14. Advance Care Planning With Patients Who Have End-Stage Kidney Disease: A Systematic Realist Review
  15. Validation of differentially methylated microRNAs identified from an epigenome-wide association study; Sanger and next generation sequencing approaches
  16. Genomic approaches in the search for molecular biomarkers in chronic kidney disease
  17. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort
  18. Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
  19. Healthcare use, costs and quality of life in patients with end-stage kidney disease receiving conservative management: results from a multi-centre observational study (PACKS)
  20. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
  21. Dietary patterns and chronic kidney disease: a cross-sectional association in the Irish Nun Eye Study
  22. Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes
  23. Retinal microvascular parameters are not associated with reduced renal function in a study of individuals with type 2 diabetes
  24. Establishing a clinical phenotype for cachexia in end stage kidney disease – study protocol
  25. Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study
  26. Arterial stiffness alone does not explain arteriovenous fistula outcomes
  27. Dietary Patterns and Retinal Vessel Caliber in the Irish Nun Eye Study
  28. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
  29. Learning to prescribe intravenous fluids: A scoping review
  30. Estimated Glomerular Filtration Rate is not Associated with Alzheimer’s Disease in a Northern Ireland Cohort
  31. Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genes
  32. Development of next generation sequencing panel for UMOD and association with kidney disease
  33. Clinician views of patient decisional conflict when deciding between dialysis and conservative management: Qualitative findings from the PAlliative Care in chronic Kidney diSease (PACKS) study
  34. High-volume haemofiltration for sepsis in adults
  35. Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3
  36. The Genetic Landscape of Renal Complications in Type 1 Diabetes
  37. A Rare Cause of Myoclonus
  38. Wnt6 regulates epithelial cell differentiation and is dysregulated in renal fibrosis
  39. Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation
  40. Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index
  41. Correction
  42. Arterial Stiffness and Arteriovenous Fistula Failure of Maturation
  43. Preoperative radial artery volume flow is predictive of arteriovenous fistula outcomes
  44. A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation
  45. Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy
  46. Ethical reasoning through simulation: a phenomenological analysis of student experience
  47. Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis
  48. Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort
  49. Arteriovenous fistula outcomes in the elderly
  50. Evaluation of the Retinal Vasculature in Hypertension and Chronic Kidney Disease in an Elderly Population of Irish Nuns
  51. Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease
  52. PAlliative Care in chronic Kidney diSease: the PACKS study—quality of life, decision making, costs and impact on carers in people managed without dialysis
  53. Genetic renal abnormalities
  54. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis
  55. Retinal microvascular network attenuation in Alzheimer's disease
  57. Genetics of Diabetic Nephropathy: a Long Road of Discovery
  58. Learning fluid prescription skills: why is it so challenging?
  59. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes
  60. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes
  61. Current tools for prediction of arteriovenous fistula outcomes
  62. Diagnosis and management of hyponatraemia: AGREEing the guidelines
  63. Genetic studies of body mass index yield new insights for obesity biology
  64. New genetic loci link adipose and insulin biology to body fat distribution
  65. Patient survival following arteriovenous fistula formation
  66. Optimizing outcomes in the elderly with end-stage renal disease—live long and prosper
  67. Retinal Vascular Caliber, Iris Color, and Age-Related Macular Degeneration in the Irish Nun Eye Study
  68. Next-generation sequencing of the mitochondrial genome and association with IgA nephropathy in a renal transplant population
  69. SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes
  71. Genetic and epigenetic factors influencing chronic kidney disease
  72. Factors influencing survival after kidney transplant failure
  73. Genetics and Genomics of Chronic Kidney Disease
  74. Surveillance of Nonmelanoma Skin Cancer Incidence Rates in Kidney Transplant Recipients in Ireland
  75. Preserving Arteriovenous Fistula Outcomes during Surgical Training
  76. β Cell Glucotoxic-Associated Single Nucleotide Polymorphisms in Impaired Glucose Tolerance and New-Onset Diabetes After Transplantation
  77. Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab
  78. Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
  79. Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
  80. Using ancestry-informative markers to identify fine structure across 15 populations of European origin
  81. Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?
  82. A genome-wide association study of anorexia nervosa
  83. New onset diabetes after transplantation: unravelling the pathophysiological process
  84. Polycystic Kidney Disease
  85. Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis
  86. Estimated Glomerular Filtration Rate Decline as a Predictor of Dialysis in Kidney Transplant Recipients
  87. Genetics of New-Onset Diabetes after Transplantation
  88. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease
  89. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit
  90. Management of hyperkalaemia
  91. Bioinformatic Resources For Diabetic Nephropathy
  92. Chromosome 2q31.1 Associates with ESRD in Women with Type 1 Diabetes
  93. Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis
  94. Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy
  95. Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
  96. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes
  97. Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes
  98. Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy
  99. Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1
  101. High-volume haemofiltration for sepsis
  102. TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation
  103. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
  104. Donor ABCB1 Variant Associates with Increased Risk for Kidney Allograft Failure
  105. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
  106. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
  107. Association of MYH9/APOL1 with chronic kidney disease in a UK population
  108. Epigenetics
  109. Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy
  110. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes
  111. Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes
  112. Association analysis of proopiomelanocortin (POMC) haplotypes in type 1 diabetes in a UK population
  113. Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes
  114. Association Analysis of Canonical Wnt Signalling Genes in Diabetic Nephropathy
  115. ANCA-associated vasculitis is linked to carriage of the Z allele of  1 antitrypsin and its polymers
  116. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  117. Genetic renal abnormalities
  118. Elevated soluble cellular adhesion molecules are associated with increased mortality in a prospective cohort of renal transplant recipients
  119. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
  120. Patterns of hospitalisation before and following initiation of haemodialysis: a 5 year single centre study
  121. Association analysis of Notch pathway signalling genes in diabetic nephropathy
  122. Managing diabetic nephropathy
  123. The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population
  124. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
  125. Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus
  126. DNA methylation profiling in cell models of diabetic nephropathy
  127. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
  128. Advances in the Genetics of Familial Renal Cancer
  129. Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure
  130. Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line
  131. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
  132. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy
  133. A GREM1 Gene Variant Associates with Diabetic Nephropathy
  134. Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus
  135. Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus
  136. Elevated Homocysteine Is a Predictor of All-Cause Mortality in a Prospective Cohort of Renal Transplant Recipients
  137. Evaluation of Five Interleukin Genes for Association with End-Stage Renal Disease in White Europeans
  138. Genetic Polymorphisms in Nitric Oxide Synthase 3 Gene and Implications for Kidney Disease: A Meta-Analysis
  139. A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy
  140. Targeted genome-wide investigation identifies novel SNPs associated with diabetic nephropathy
  141. High-volume haemofiltration for sepsis
  142. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy
  143. The Impact of Admissions for the Management of End-Stage Renal Disease on Hospital Bed Occupancy
  144. Association of microsatellite markers on chromosomes 6q27 region and 10p15 region with end-stage renal disease in a UK renal transplant population
  145. Replication studies based on findings from a genome-wide DNA microsatellite screen in diabetic nephropathy
  146. The changing pattern of adult primary glomerular disease
  147. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
  148. Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines
  149. The coronary artery disease SNP, rs4420638, is associated with diabetic nephropathy rather than end-stage renal disease
  150. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
  151. Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients
  152. Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy
  153. Annotated chromosome maps for renal disease
  154. Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus
  155. HLA antigen frequencies and Wegener's granulomatosis
  156. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders
  157. Association of Genetic Variants at 3q22 with Nephropathy in Patients with Type 1 Diabetes Mellitus
  158. Early acute kidney injury in Northern Ireland ICUs
  159. Genetics of Diabetic Nephropathy: Are There Clues to the Understanding of Common Kidney Diseases?
  160. The Challenge of Doing What Is Right in Renal Transplantation: Balancing Equity and Utility
  161. The uptake of cervical cancer screening by renal transplant recipients
  162. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy
  163. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes
  164. The evolution of renal transplantation in clinical practice: for better, for worse?
  165. Investigation ofAdducin 2 (beta)DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes
  166. Heme Oxygenase-1 Gene Promoter Polymorphisms and Outcomes of Clinical Renal Transplantation
  167. Heme Oxygenase 1: Does It Have a Role in Renal Cytoprotection?
  168. Hypokalaemic paralysis precipitated by distal renal tubular acidosis secondary to Sjögren's syndrome
  169. Critiques of Clinical Guidelines in Nephrology: Anaemia
  170. Pathophysiology of anemia and erythrocytosis
  171. Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy
  172. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease
  173. Troponin T is an independent predictor of mortality in renal transplant recipients
  174. Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication...
  175. Decreased Serum Retinol Is Associated with Increased Mortality in Renal Transplant Recipients
  176. In Reply
  177. Association of VEGF-1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus
  178. Genetic renal abnormalities
  179. Gene discovery in diabetic nephropathy
  180. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation
  181. Association of Functional Heme Oxygenase-1 Gene Promoter Polymorphism with Renal Transplantation Outcomes
  182. Warning Flags for Erythropoiesis-Stimulating Agents and Cancer-Associated Anemia
  183. Reply Orlistat and renal failure
  184. Common polymorphisms of thePAI1gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes
  185. Resequencing of genes for transforming growth factor β1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy
  186. Impaired Downregulation Following Erythropoietin Receptor Activation in Non-Small Cell Lung Carcinoma
  187. Are gatekeepers to renal services referring patients equitably?
  188. Association between Haptoglobin Gene Variants and Diabetic Nephropathy: Haptoglobin Polymorphism in Nephropathy Susceptibility
  189. Cost Should Be the Principal Determinant of Choice of Erythropoiesis-Stimulating Agent in Chronic Haemodialysis Patients
  190. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
  191. Identifying genes for diabetic nephropathy--current difficulties and future directions
  192. Rapidly progressive renal failure associated with successful pharmacotherapy for obesity
  193. The PAX4 gene variant A1168C is not associated with early onset Type 1 diabetes in a UK population
  194. Cardiac tamponade … a wire too far?
  195. Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy
  196. A Genome-Wide DNA Microsatellite Association Screen to Identify Chromosomal Regions Harboring Candidate Genes in Diabetic Nephropathy
  197. Induction of Signalling in Non-Erythroid Cells by Pharmacological Levels of Erythropoietin
  198. Late referral for assessment of renal failure
  199. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population
  200. Cytokine gene polymorphisms in ischaemic heart disease: investigation using family-based tests of association
  201. Role of  -adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy
  202. Association Between Variation in the Actin-Binding Gene Caldesmon and Diabetic Nephropathy in Type 1 Diabetes
  203. Association of intercellular adhesion molecule-1 gene with type 1 diabetes
  204. Is screening for factor V leiden and prothrombin G20210A mutations in renal transplantation worthwhile? results of a large single-center U.K. study1
  205. Dialysis Clinic: Skin Thickness and Subcutaneous Erythropoietin
  206. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
  207. Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis
  208. The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes
  209. EPO's Alter Ego: Erythropoietin Has Multiple Actions
  210. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure
  211. A nested primer set targeting the cytomegalovirus glycoprotein B gene
  212. Influence of progressive renal dysfunction in chronic heart failure
  213. AINT/ERIC/TACC: An Expanding Family of Proteins with C-terminal Coiled Coil Domains
  214. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus
  215. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population
  216. The Influence of Transforming Growth Factor-β1 Gene Polymorphisms on the Severity of Gingival Overgrowth Associated With Concomitant Use of Cyclosporin A and a Calcium Channel Blocker
  217. Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells
  218. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
  219. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
  220. Is There an Association Between Angiotensin-Converting Enzyme Gene Variants and Chronic Nonproductive Cough?
  221. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus
  222. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth
  223. The Ferroxidase Activity of Caeruloplasmin Is Reduced in Haemodialysis Patients
  224. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy
  225. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
  226. Erythropoietin production: evidence for multiple oxygen sensing pathways
  227. Regulation of Erythropoietin Gene Expression Depends on Two Different Oxygen-Sensing Mechanisms
  228. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families
  229. Homocysteine and B-group vitamins in renal transplant patients
  230. MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes
  231. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control
  232. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
  233. Plasma Glutathione Peroxidase Activity Is Reduced in Haemodialysis Patients
  235. Sequence characterisation and expression of homeobox HOX A7 in the multi-potential erythroleukaemic cell line TF-1
  236. National scientific medical meeting 1997 abstracts
  237. Autosomal dominant Alport syndrome linked to the type IV collage  3 and  4 genes (COL4A3 and COL4A4)
  238. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis
  239. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis
  240. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
  241. A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM
  242. Production and Isolation of the Recombinant N-Lobe of Human Serum Transferrin from the Methylotrophic YeastPichia pastoris
  244. Cytosolic phospholipase A2gene expression in rat mesangial cells is regulated post-transcriptionally
  245. ACE gene typing
  246. Isolation of promoter for cytosolic phospholipase A2 (cPLA2)
  247. Reduced Phospholipase A2 Activity Is Not Accompanied by Reduced Arachidonic Acid Release
  248. Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2in glomerular mesangial cells
  249. Renal replacement therapy in multiple myeloma and systemic amyloidosis
  250. MicroCorrespondence
  251. Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane.
  252. HLA antigen frequencies and Wegener's granulomatosis
  253. Outcome of pregnancy following renal transplantation
  254. Erythropoietin production in kidney tubular cells
  255. Subcutaneous Erythropoietin Therapy and Hypertensive Encephalopathy
  256. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice
  257. Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane.